Improvements in Quality of Life and Work Productivity Make Omalizumab Cost-Effective for the Treatment of Chronic Spontaneous Urticaria
AuthID
P-00P-NEB
P-00P-NEB
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service